Bliss GVS Pharma Limited — Others, 28-07-2025: ESOP/ESOS/ESPS

Bliss GVS Pharma's ESOP Allotment Committee approved the allotment of 74,000 new equity shares to eligible employees exercising their stock options under the 2019 plan. This increases the company's issued, subscribed, and paid-up share capital from Rs. 10.55 Cr to Rs. 10.56 Cr. Consequently, the total number of issued shares increased to 10.56 crore shares. Each new share has a face value of Re. 1 and was issued at an exercise price of Rs. 43. This allotment results in minor dilution for existing shareholders but helps align employee interests with company growth.